PALLIATIVE ASSESSMENT COHORT IN THE GERIATRIC EMERGENCY SETTING

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65+
SponsorUniversity Hospital Bispebjerg and Frederiksberg

About this trial

The PALMA project is part of a larger palliative research program COPAL in Capital Region of Denmark led by Professor Tom Møller. PALMA aims to improve palliative care for geriatric patients transitioning from emergency-hospital to primary care. The project addresses the lack of a systematic approach for assessing and managing palliative symptoms in geriatric patients to enhance communication between hospitals and municipal health care services.

The PALMA cohort investigates the applicability of systematic palliative assessment (EORTC-C15 PAL) in the geriatric emergency setting combined with measures of frailty, socio-demographic risks, and cross-sectoral healthcare support.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

Patients in the geriatric emergency department are 65 years of age or older and referred by their own general practitioner or specialist for assessment and treatment of an acute medical problem. Approximately one-third are admitted and two-thirds are discharged to home facilities.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Prospective observational cohort study.

    Other intervention

    No systematic approach exists for symptom assessment, management, and reporting in delivered basic palliative care within the Danish healthcare system, implying considerable variation in hospital-based palliative care. The PALMA study consists of two superior phases divided in a development and an implementation stage that anchors basic palliative assessment and management within existing geriatric workflows and cross-sectoral collaborative care. The PALMA cohort will test the applicability of the EORTC-C15-PAL questionnaire along with measures of clinical frailty and sociodemographic risk factors. The development phase will enable the development of a clinical algorithm for elderly patients' need for cross-sectoral palliation care planning.

  • A prospective observational cohort study

    Other intervention

    Observational design

Treatment groups

300 Participants
are divided into 1 treatment group
Group A: Palliative assessment group of acutely admitted older patients2 interventions

Trial outcomes

Primary outcomes

1

Mortality

Mortality rates at 3 and 6 months

Time frame
Patient observation time is 6 months

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: